Trial intelligence / Profile preview

Safety of triamcinolone after endoscopic radial incision and cutting for benign lower GI stenosis

jRCTs021220004Completed

Start
Apr 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of triamcinolone acetonide in lower gastrointestinal tract stenosis. Primary endpoint: Primary safety endpoint. Started Apr 2022; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

lower gastrointestinal tract stenosis

Beyond the preview

Go deeper on jRCTs021220004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs021220004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call